持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/06/04 | 4,200 | 4,210 | 4,105 | 4,175 | -5 | -0.1% | 31,600 |
2020/06/03 | 4,240 | 4,240 | 4,165 | 4,180 | -45 | -1.1% | 29,000 |
2020/06/02 | 4,110 | 4,235 | 4,075 | 4,225 | +150 | +3.7% | 54,800 |
2020/06/01 | 4,205 | 4,220 | 4,065 | 4,075 | -100 | -2.4% | 35,300 |
2020/05/29 | 4,095 | 4,200 | 4,095 | 4,175 | +85 | +2.1% | 78,000 |
2020/05/28 | 4,075 | 4,090 | 4,020 | 4,090 | +40 | +1% | 49,500 |
2020/05/27 | 4,015 | 4,070 | 3,990 | 4,050 | +5 | +0.1% | 40,600 |
2020/05/26 | 4,010 | 4,055 | 3,980 | 4,045 | +55 | +1.4% | 43,200 |
2020/05/25 | 3,940 | 3,990 | 3,900 | 3,990 | +140 | +3.6% | 21,100 |
2020/05/22 | 3,955 | 3,955 | 3,845 | 3,850 | -85 | -2.2% | 35,700 |
2020/05/21 | 4,015 | 4,015 | 3,935 | 3,935 | -70 | -1.7% | 36,200 |
2020/05/20 | 4,025 | 4,035 | 3,950 | 4,005 | ±0 | ±0% | 45,300 |
2020/05/19 | 4,060 | 4,065 | 3,985 | 4,005 | +55 | +1.4% | 42,800 |
2020/05/18 | 4,060 | 4,060 | 3,930 | 3,950 | -70 | -1.7% | 41,000 |
2020/05/15 | 4,080 | 4,080 | 3,985 | 4,020 | -10 | -0.2% | 57,500 |
2020/05/14 | 4,185 | 4,190 | 4,030 | 4,030 | -155 | -3.7% | 39,100 |
2020/05/13 | 4,110 | 4,200 | 4,100 | 4,185 | +60 | +1.5% | 54,700 |
2020/05/12 | 4,230 | 4,240 | 4,125 | 4,125 | -40 | -1% | 33,100 |
2020/05/11 | 4,120 | 4,165 | 4,105 | 4,165 | +70 | +1.7% | 30,300 |
2020/05/08 | 4,100 | 4,105 | 4,040 | 4,095 | +65 | +1.6% | 37,900 |
2020/05/07 | 4,065 | 4,090 | 4,005 | 4,030 | -120 | -2.9% | 68,900 |
2020/05/01 | 4,220 | 4,235 | 4,145 | 4,150 | -50 | -1.2% | 43,700 |
2020/04/30 | 4,225 | 4,250 | 4,180 | 4,200 | -20 | -0.5% | 67,900 |
2020/04/28 | 4,185 | 4,235 | 4,120 | 4,220 | +60 | +1.4% | 50,700 |
2020/04/27 | 4,150 | 4,180 | 4,080 | 4,160 | +60 | +1.5% | 52,800 |
2020/04/24 | 4,120 | 4,145 | 4,045 | 4,100 | -10 | -0.2% | 63,200 |
2020/04/23 | 4,090 | 4,125 | 4,030 | 4,110 | +105 | +2.6% | 48,100 |
2020/04/22 | 4,020 | 4,035 | 3,955 | 4,005 | -15 | -0.4% | 44,100 |
2020/04/21 | 4,075 | 4,110 | 3,995 | 4,020 | -50 | -1.2% | 43,900 |
2020/04/20 | 4,110 | 4,185 | 4,070 | 4,070 | -55 | -1.3% | 33,400 |
2020/04/17 | 4,235 | 4,235 | 4,095 | 4,125 | -40 | -1% | 46,000 |
2020/04/16 | 4,130 | 4,230 | 4,080 | 4,165 | +20 | +0.5% | 55,900 |
2020/04/15 | 4,235 | 4,235 | 4,050 | 4,145 | -90 | -2.1% | 132,400 |
2020/04/14 | 4,335 | 4,360 | 4,205 | 4,235 | -95 | -2.2% | 85,200 |
2020/04/13 | 4,390 | 4,415 | 4,295 | 4,330 | -65 | -1.5% | 44,500 |
2020/04/10 | 4,265 | 4,395 | 4,160 | 4,395 | +145 | +3.4% | 52,700 |
2020/04/09 | 4,215 | 4,290 | 4,145 | 4,250 | +20 | +0.5% | 53,900 |
2020/04/08 | 4,075 | 4,270 | 4,045 | 4,230 | +155 | +3.8% | 102,400 |
2020/04/07 | 3,985 | 4,095 | 3,940 | 4,075 | +40 | +1% | 77,900 |
2020/04/06 | 3,890 | 4,060 | 3,825 | 4,035 | +250 | +6.6% | 70,100 |
2020/04/03 | 3,815 | 3,915 | 3,740 | 3,785 | +10 | +0.3% | 62,500 |
2020/04/02 | 3,885 | 3,985 | 3,765 | 3,775 | -145 | -3.7% | 78,500 |
2020/04/01 | 4,110 | 4,265 | 3,920 | 3,920 | -250 | -6% | 90,200 |
2020/03/31 | 4,375 | 4,435 | 4,135 | 4,170 | -410 | -9% | 136,000 |
2020/03/30 | 4,505 | 4,590 | 4,350 | 4,580 | -10 | -0.2% | 135,200 |
2020/03/27 | 4,460 | 4,590 | 4,365 | 4,590 | +200 | +4.6% | 153,400 |
2020/03/26 | 4,145 | 4,410 | 4,030 | 4,390 | +235 | +5.7% | 141,200 |
2020/03/25 | 4,095 | 4,195 | 4,000 | 4,155 | +155 | +3.9% | 87,500 |
2020/03/24 | 4,175 | 4,175 | 3,855 | 4,000 | -105 | -2.6% | 92,400 |
2020/03/23 | 4,300 | 4,395 | 3,915 | 4,105 | -75 | -1.8% | 174,800 |
1251~
1300
件表示中 / 3740件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 290,800円 | +5.1% | -7.0% | 2.75% | 19.09倍 | 0.79倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
サンバイオ | 216,600円 | - | - | 0.00% | - | 100.32倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ゼリア新薬 | 205,100円 | +3.1% | -6.5% | 2.34% | 9.52倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 150,000円 | -2.4% | -52.3% | 3.80% | 17.95倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 88,200円 | +20.3% | - | 0.00% | 156.38倍 | 1.16倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム